Adverse selection Treatment selection among BTK inhibitors for the first-line treatment of CLL Martin E. Berry March 10, 2022
Adverse selection Safety Considerations in mCSPC and Selection of Androgen Receptor Pathway Inhibitors Martin E. Berry March 10, 2022
Adverse selection Treatment Selection Strategies for Chronic Lymphocytic Leukemia Martin E. Berry February 22, 2022
Adverse selection Catheter ablation: Developments and choice of technique Martin E. Berry February 19, 2022
Adverse selection Treatment selection based on patient and treatment factors Martin E. Berry February 7, 2022
Adverse selection Angle PLC announces potential in screening immunotherapy treatments Martin E. Berry January 21, 2022
Adverse selection Ixekizumab for psoriatic arthritis: safety, efficacy and patient selection Martin E. Berry December 24, 2021
Adverse selection Molecular Selection Raises pCR Levels in Early Breast Cancer Trial Martin E. Berry December 20, 2021
Adverse selection The OptimizeRx survey addresses treatment selection, Martin E. Berry December 15, 2021
Adverse selection OptimizeRx survey covers selection, discontinuation and change of treatment in anaplasia … | Your money Martin E. Berry December 15, 2021
Adverse selection Cost and staff time spent managing side effects can make treatment selection in CLL easier Martin E. Berry December 13, 2021
Adverse selection Treatment selection could be informed by the cost and time spent on managing toxicity in CLL Martin E. Berry December 13, 2021
Adverse selection Updated safety data and treatment selection in nmCRPC Martin E. Berry December 2, 2021
Adverse selection Optimization of the selection of first line TKIs for Advanced HCC Martin E. Berry November 24, 2021